Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product ; volume:35 ; number:5 ; day:22 ; month:7 ; year:2021 ; pages:563-577 ; date:9.2021
BioDrugs ; 35, Heft 5 (22.7.2021), 563-577, 9.2021
- Creator
-
Hutterer, Katariina M.
Ip, Anna
Kuhns, Scott
Cao, Shawn
Wikström, Mats
Liu, Jennifer
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-021-00492-9
- URN
-
urn:nbn:de:101:1-2021122521585412930743
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hutterer, Katariina M.
- Ip, Anna
- Kuhns, Scott
- Cao, Shawn
- Wikström, Mats
- Liu, Jennifer
- SpringerLink (Online service)
Other Objects (12)
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
Analytical Characterization for Similarity Assessment Between an Aflibercept Biosimilar SB15 and Reference Product (Eylea®)
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Treating C3 glomerulopathy with eculizumab
Treating C3 glomerulopathy with eculizumab
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
959, Wagen No 959
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
Analytical Characterization for Similarity Assessment Between an Aflibercept Biosimilar SB15 and Reference Product (Eylea®)
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Treating C3 glomerulopathy with eculizumab
Treating C3 glomerulopathy with eculizumab
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
959, Wagen No 959
Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
Analytical Characterization for Similarity Assessment Between an Aflibercept Biosimilar SB15 and Reference Product (Eylea®)
Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
Treating C3 glomerulopathy with eculizumab
Treating C3 glomerulopathy with eculizumab
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab